JPRN-UMIN000005901
Completed
Phase 3
A phase III randomized trial of adjuvant therapy with irsogladine maleate for the patient with completely resected non-small cell lung cancer - A phase III trial of adjuvant therapy with irsogladine maleate for the resected lung cancer patient
Japanese Northern East Area Thoracic Surgery Study Group (JNETS)0 sites310 target enrollmentJuly 2, 2011
Conditionsnon-small cell lung cancer
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- non-small cell lung cancer
- Sponsor
- Japanese Northern East Area Thoracic Surgery Study Group (JNETS)
- Enrollment
- 310
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •multiple cancer within 5 years sever organ failure past history of radiotherapy/chemotherapy women with pregnancy or breast feeding
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
A randomized phase III trial of adjuvant therapy with locoregional IFN-beta versus observation in stage II/III cutaneous melanoma (JCOG1309, J-FERON Trial)Cutaneous melanomaJPRN-UMIN000017494Japan Clinical Oncology Group (JCOG)240
Recruiting
Not Applicable
Randomized Phase III Trial of the need for adjuvant chemotherapy in stage I epithelial ovarian cancer after comprehensive staging surgeryKCT0005869The Catholic University of Korea, Seoul St. Mary's Hospital360
Recruiting
Phase 3
Randomized Phase III Trial of the need for adjuvant chemotherapy in stage I epithelial ovarian cancer after comprehensive staging surgeryStage I epithelial ovarian cancer after comprehensive staging surgeryJPRN-UMIN000008481Japanese Gynecologic Oncology Group360
Recruiting
Phase 3
Japanese Gynecologic Oncology Group 3020 (ECO trial)Epithelial ovarian cancerEarly OvarianCancerD000077216JPRN-jRCTs031180423TANABE HIROSHI300
Completed
Not Applicable
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By SurgeryPER-155-08EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG),